Skip to main content
. Author manuscript; available in PMC: 2024 Jul 5.
Published in final edited form as: Breast Cancer Res Treat. 2023 Mar 22;199(2):243–252. doi: 10.1007/s10549-023-06881-8

Table 2.

Multivariate Cox proportional hazard models: NSABP B-41

Variables RFI (n = 519)
OS (n = 522)
HR (95% CI) p-value HR (95% CI) p-value

Treatment: L vs T 1.37 (0.80, 2.34) 0.26 1.46 (0.68, 3.11) 0.33
Treatment: TL vs T 0.70 (0.37, 1.32) 0.27 0.58 (0.22, 1.51) 0.27
Clinical tumor size (≥ 4.1 cm vs 2–4 cm) 2.42 (1.45, 4.02) < 0.001 2.29 (1.12, 4.69) 0.02
Clinical nodal status (pos. vs neg.) 1.63 (0.99, 2.68) 0.06 1.26 (0.64, 2.49) 0.51
Hormone receptor status (pos. vs neg.) 0.59 (0.37, 0.93) 0.02 0.28 (0.14, 0.56) < 0.001
Age (≥ 50 vs < 50 years) 0.71 (0.44, 1.14) 0.15 0.60 (0.30, 1.19) 0.14